NCT06949449Completed
Upper Limb Function in Mental Health Disorders
Upper Limb Functional Capacity in Individuals Diagnosed With Mental Disorders: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 29 Apr 2025
Brief summary (registry, in English)
Background: Individuals with mental disorders (MD) often experience motor issues, yet upper limb functionality remains understudied. Objective: To compare upper limb function in individuals with and without MD, focusing on motor capacity, dexterity, and performance. Design: Cross-sectional, qualitative, multicenter study. Methods: Assessed strength, motor skills, sensitivity, and daily function. Used T-test, Mann-Whitney U, Spearman correlation, and Chi-square.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 38 (actual)
- First submitted
- 8 Apr 2025
- Start date
- 1 Oct 2024
- Primary completion date
- 25 Jan 2025
- Lead sponsor
- Universidad de Burgos
- Diseases
- Multiple sclerosis
- NCT number
- NCT06949449
What you commit to
- Study type: Observational
- Participants enrolled: 38
- From 1 Oct 2024 to the primary completion date, 25 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of neurological conditions, such as multiple sclerosis, stroke, or similar disorders.
- History of upper limb rehabilitation within the past six months.
- Any acute or chronic condition affecting the upper limb that could interfere with the results, including but not limited to arthritis, osteoarthritis, or carpal tunnel syndrome.
Who the study is looking for
- Mental Disorder Group
- Participants with a mental disorder (MD) had to meet the following criteria:
- A formal diagnosis of a mental disorder according to the DSM-V.
- Aged between 18 and 65 years.
- Treatment stability, defined as being under stable pharmacological and psychiatric treatment for at least three months.
- Clinical stability, meaning no acute psychiatric episodes in the last three months that could interfere with participation in the study.
- Ability to follow instructions and communicate effectively, confirmed by scoring at least 23 points on the Mini-Mental State Examination (MMSE).
- Control Group (Healthy Participants)
- Healthy individuals were required to meet the following inclusion criteria:
- Aged between 18 and 65 years.
- Ability to follow instructions and communicate effectively, also defined by a minimum MMSE score of 23.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Burgos Coordinator of this site? Confirm its status | Burgos | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.